PEB 6.16% 15.5¢ pacific edge limited ordinary shares

Ann: GENERAL: PEB: Correction on Pacific Edge Limited Patent Issue

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    • Release Date: 26/11/14 12:33
    • Summary: GENERAL: PEB: Correction on Pacific Edge Limited Patent Issue
    • Price Sensitive: No
    • Download Document  846B
    					PEB
    26/11/2014 12:33
    GENERAL
    PRICE SENSITIVE
    REL: 1233 HRS Pacific Edge Limited
    
    GENERAL: PEB: Correction on Pacific Edge Limited Patent Issue
    
    26 November 2014
    
    Correction on Pacific Edge Limited Patent Issue
    
    Pacific Edge Limited ("the Company") advises the market that it has
    incorrectly posted the NZX release for the issue of its bladder cancer patent
    in Europe.
    
    The Company's bladder cancer patent has not issued however the patent has
    successfully completed examination and the Company has been advised by the
    European Patent Office that the patent will issue by February 2015.
    
    The Company wishes to inform the market that Pacific Edge's colorectal cancer
    biomarker patent has issued in Europe. Details of this are provided in the
    Company's separate announcement.
    
    End
    End CA:00258139 For:PEB    Type:GENERAL    Time:2014-11-26 12:33:04
    				
 
watchlist Created with Sketch. Add PEB (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.